Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IINN
IINN logo

IINN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Inspira Technologies Oxy BHN Ltd (IINN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
0.410
1 Day change
-6.22%
52 Week Range
1.650
Analysis Updated At
2026/05/01
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

IINN is not a good buy right now for a beginner long-term investor with $50,000-$100,000. The stock lacks bullish technical confirmation, has no recent news catalyst, no positive insider or hedge fund activity, and no strong proprietary buy signal. Based on the current data, I would not buy it now.

Technical Analysis

The technical picture is weak. MACD histogram is below zero and negatively expanding, which points to worsening momentum. The moving averages are bearish with SMA_200 > SMA_20 > SMA_5, showing a downtrend across short, medium, and long horizons. RSI_6 at 28.25 is near oversold territory, but it is not enough by itself to confirm a reversal. Price is also below the pivot at 0.534 and below the first support at 0.451, with the next support at 0.399. Pre-market price is 0.4319, which sits near support but without a clear reversal signal. The near-term stock trend estimate is also weak, with a 40% chance of -0.4% next day and -0.96% next week.

Positive Catalysts

  • No recent news was reported in the last week. There are no notable positive insider or hedge fund trends, and no AI Stock Picker or SwingMax buy signal today. The only mild positive is that the stock is trading near support levels, which could attract short-term value interest, but there is no confirmation of a catalyst.

Neutral/Negative Catalysts

  • No recent news, no supportive option sentiment, neutral insider activity, neutral hedge fund activity, and no congress trading data. Technical indicators are bearish, and the stock is in a broader downtrend. The latest quarter showed no revenue growth, negative net income of -3,008,000, and negative EPS of -0.45, indicating weak profitability.

Financial Performance

Latest reported quarter: 2023 Q4. Revenue was 0, showing no growth. Net income was -3,008,000 and EPS was -0.45, both negative. Gross margin was 0.69, which is relatively strong, but the company is still not generating meaningful sales or profits, so overall financial performance remains weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no evidence of a recent bullish revision. Wall Street pros would likely see more cons than pros here: weak financials, lack of revenue growth, no recent catalyst, and bearish technicals outweigh any speculative upside. Without analyst support, the stock does not look institutionally favored at the moment.

Wall Street analysts forecast IINN stock price to rise
Analyst Rating
0
Wall Street analysts forecast IINN stock price to rise
Buy
Hold
Sell
0
Current: 0.434
sliders
Low
0
Averages
0
High
0
0
Current: 0.434
sliders
Low
0
Averages
0
High
0
Litchfield Hills
Theodore O'Neill
Buy
initiated
$2
AI Analysis
2025-06-02
Reason
Litchfield Hills
Theodore O'Neill
Price Target
$2
AI Analysis
2025-06-02
initiated
Buy
Reason
Litchfield Hills analyst Theodore O'Neill initiated coverage of Inspira Technologies with a Buy rating and $2 price target. Inspira is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions, the analyst tells investors in a research note. The firm says the company has a "well-protected technology moat" that includes both patented technology and technical trade secrets.

People Also Watch